-
Beyond the Research Assistant: Innovative Uses of AI in Health Preference Research
-
Designing for Access: Early Integrated Evidence Generation Planning in the Era of Expanded Value Frameworks
-
Harnessing AI to Transform HEOR and Real‑World Evidence Generation in Rare Diseases: Regulatory Expectations, Opportunities, and Practical Use Cases
-
ISPOR Top 10 HEOR Trends - What Are The Key Themes for 2026-27?
-
HEOR Career Development for New Professionals: Things I Wish I Knew
-
When Evidence Drives Adoption: How Investors Evaluate Diagnostic, Device, and MedTech Innovation in a Policy Constrained Market
-
Whole Health Evaluation of Multi-System Risk: GLP-1 Insights
-
September 6: Applied Generative AI for HEOR: Introduction - In Person at ISPOR Asia Pacific Summit 2026
-
September 6: Practical Applications of Large Language Models for Real-World Evidence Generation and HEOR - In Person at ISPOR Asia Pacific Summit 2026
-
September 6: Budget Impact Analysis in Practice: A Hands-On Course in Strategic Conceptual Design, Model Building, and Communication - In Person at ISPOR Asia Pacific Summit 2026
-
September 14-17: Introduction to Health Economics and Outcomes Research - Virtual
-
September 23-24: Evaluation of Digital Health Technologies, Medical Devices, and Pharmaceuticals and the Challenges to Consider - Virtual
-
Creating Defensible Evidence With External Control Arms
-
Endpoints That Matter: Integrating Patient-Relevant Outcomes in HTA
-
Evolving HTA Systems in Latin America: Access & Innovation
-
Personalized Outcome Assessment Using Goal Attainment Scaling
-
November 8: Risk-Sharing/Performance-Based Arrangements in Developing Countries - In Person at ISPOR Europe 2026
-
November 8: Applied Generative AI for HEOR: Introduction - In Person at ISPOR Europe 2026
-
November 8: Health Economic Modeling in R for Decision Making: Assessment, Adaptation, and AI-Assisted Validation - In Person at ISPOR Europe 2026
-
November 8: Developing Decision-Grade Real-World Evidence - In Person at ISPOR Europe 2026
